INTRODUCTION
Since the sentinel lymph node biopsy (SLNB) technique was first introduced for evaluating the axilla of breast cancer patients, the morbidity associated with axillary dissection has been greatly reduced. However, the rate of lymphedema has ranged from 0% to 13% despite the use of the SLNB, (1) (2) (3) and the rates are higher in patients who undergo conventional axillary lymph node dissection (ALND). If there are two independent lymphatic systems, one from the breast (the breast lymphatics) and the other from the arm (the arm lymphatics), and if the metastasis involving the axilla occurs only in the lymph nodes from the breast lymphatics, then mapping and preserving the arm lymphatics might decrease the likelihood of disrupting the lymphatic drainage of the arm and this could result in decreasing the risk of lymphedema both for ALND and SLNB. Thus, we performed this pilot study to determine if there are two independent lymphatic drainage systems, one from the breast and one from the arm, with no metastasis at the arm sentinel lymph node (SLN; the first drained lymph node by definition). The final goal is to prevent lymphedema by performing arm SLN detection, by preserving the arm lymphatic drainage during ALND or SLNB.
METHODS

Patients
Twenty one patients underwent surgery for breast cancer with arm SLN detection from March to July 2008 at Samsung Medical Center. Among them, 10 patients had SLNB alone and 11 patients required ALND for various reasons (Table 1) .
Purpose:
The objective of arm sentinel lymph node (SLN) detection were to identify the presence of different drainage tracts of the breast and arm lymphatics and eventually to prevent lymphedema after an axillary procedure. Methods: Twenty one patients underwent surgery for breast cancer, with arm SLN detection, from March to July 2008 at Samsung Medical Center. We used the 99 Tc-tin colloid isotope in two patients, blue dye in 18 and green dye in one for the arm SLN detection. Results: Stained and/or hot nodes from the arm lymphatics were identified in 15 of the 21 patients (71.4 %). Among the 15 patients who had the arm SLN identified, one patient had a metastasis at the arm SLN, and another patient had common breast and arm lymphatic drainage. Conclusion: Identification of the arm lymphatic drainage was possible. Since there were cases of common pathway of the arm and breast lymphatics and metastasis of the arm SLN, we cannot conclude that the arm SLN detection was safe and effective. A subsequent study for identifying the presence of two different drainage systems of the breast and arm lymphatics and confirmation of no metastasis at the arm SLN is needed.
Arm sentinel node detection
For mapping the arm lymphatics, we used the 99 Tc-tin colloid isotope in two patients, blue dye (0.8% indigocarmine, 2-3 mL) in 18 patients and green dye (1% indocyanine green [ICG], 2.5 mL) in one patient. With using the 99 Tc-tin colloid isotope, we preoperatively injected 4 mCi of the isotope at the 2nd and 3rd inter-digital spaces and we assessed the lymphoscintigraphy after one to two hours. A gamma probe also was used to intraoperatively locate the signals. The dyes were intraoperatively injected at the inner side of the upper arm along the medial intermuscular groove 5 to 10 min before the incision. After an injection of blue or green dye in the upper arm or after an injection of the isotope in the hand, the surgeon performed the SLNB or ALND to identify the arm and/or breast SLN. The lymph node which took the armside injected materials (dye or isotope) defined as an arm sentinel lymph node. For the cases that we could find the SLN in the breast lymphatics and/or the arm lymphatics, we removed them separately, and we examined them for the presence of metastases. We thought that the union of the substances which injected in the arm and breast side resulted from common pathway of breast and arm lymphatics.
Breast sentinel node detection
In the case of doing breast sentinel lymph node biopsy, we routinely preoperatively inject 0.5 mCi of 99 Tc-tin colloid isotope in the subareolar lymphatic plexus. The lymphoscintigraphy is obtained one to three hours after the injection. Only the isotope was used for the first eight cases for detecting a breast SLN. To increase the specificity for breast SLN detection, we adopted the triple method of checking for which the isotope and two different dyes (blue and green) are used (Tables 2, 3 ).(4) Among the 15 patients in whom an arm SLN was identified, one patient had metastasis at the arm SLN, and another patient had a common breast and arm lymphatic drainage system (Table 3 ). There were no serious complications except for prolonged arm tattooing. 
RESULTS
Clinical characteristics of the patients
DISCUSSION
The status of the axillary lymph nodes is an important prognostic factor for the treatment of breast cancer. ALND has been widely adopted to identify the exact lymph node status; in addition, SLNB has become a standard treatment method for early stage breast cancers. Lymphedema The anatomy of the relationship between the arm and breast lymphatics has not yet been defined. It is assumed that there is a different lymphatic drainage system for the arm and breast lymphatic drainage to the axilla. Evaluation of the lymphatic systems is difficult because of the scarcity of detection methods, the small lymphatic channels and the difficult accessibility. Hama et al. (11) showed in a mouse model two different drainage systems by performing two-color spectral fluorescence lymphangiography. Previous studies about the arm SLN also reported that there were variations in the location of lymphatics from arm. (8, 9) They both showed the absence of concordance of the arm and breast lymphatic drainage.
However, other researchers that performed cadaver studies have reported that the main sentry node in the axilla had the same drainage from the upper limb and the anterior upper torso. (12, 13) In addition, in a study of the arm sentinel by Boneti et al., (14) common pathway of the blue arm lymphatics with the breast lymphatics together with a hot SLN was observed in five (3.9%) patients, although these lymph nodes in the five patients did not contain metastases. In our study, there were two cases of common pathway of the arm and breast SLN, and the arm SLN in one case showed a breast cancer metastasis. Therefore, detection of the arm SLN should be tested in future studies with a larger number of patients and long-term follow up because of the risk of missing a positive axillary node when preserving the arm SLN.
A previous report on detecting the arm SLN showed that lymphazurin (isosulfan blue dye) (8) and patent blue dye (9) could be used for detecting the arm SLN. For the cases that underwent simultaneous breast SLNB and arm SLNB in a previous report, isotope was additionally used for the detection of the breast SLN. We attempted several methods for detecting the arm SLN with using isotope and other dyes (indigocarmine, ICG) because of the risk of severe skin reactions, including necrosis and dermolysis, for the cases with injecting methylene blue dye into the subcutaneous tissue or dermis and due to the difficulty with obtaining lymphazurin ( Table 2 ). This is the first report of a triple detection method being used for increasing the detection rate of the sentinel lymph node.
This method was used in three cases. Blue dye for the arm lymphatic drainage and green dye and isotope for the breast SLNB were used in two cases. This method can be applied with other combinations of using an isotope for the arm SLN and blue and green dyes for the breast SLN. Although differentiation of these colors was very difficult, it was possible to differentiate the blue and green dye-stained lymph nodes. Some reports have can be used to avoid prolonged tattooing. We used an isotope method for detecting the arm SLN in 2 cases.
Our study is limited by the small number of patients and the relative inexperience with the procedure we used.
Identification and preservation of the arm lymphatic drainage is a novel procedure. Identification and preservation of the arm lymphatic drainage is more difficult than simple biopsy and detection of a SLN, and it likely requires a longer learning curve than that for breast SLNB. The previously reported results for the identification rate and the dissection of lymphatic drainage (71% vs 47%) suggest this discrepancy. (9) In our preliminary study, metastasis to the arm SLN and a case with common lymphatic drainage posed difficulty for the concept of two separate lymphatic drainage systems. Therefore, the usefulness and safety of arm sentinel lymph node biopsy remains unclear. Nos et al.
recently reported on three patients who had breast metastasis in their arms' sentinel nodes. (18) We also found the presence of metastasis in an arm SLN. In addition, we introduced the first triple detection method.
CONCLUSION
Identifying the arm sentinel lymphatic drainage is possible. Because there were cases of common pathway of the arm and breast lymphatics and metastasis of the arm SLN, we cannot conclude that the arm SLN detection was safe and effective. A subsequent study is needed for the identification of the presence of two different drainage systems of the breast and arm lymphatics and for confirming the absence of metastasis at the arm SLN.
